Vor Biopharma CEO Robert MBBS' 2023 pay falls 40% to $2.7M
Vor Biopharma reports 2023 executive compensation
By ExecPay News
Published: April 9, 2024
Vor Biopharma reported fiscal year 2023 executive compensation information on April 9, 2024.
In 2023, three executives at Vor Biopharma received on average a compensation package of $1.8M, a 37% decrease compared to previous year.
Average pay of disclosed executives at Vor Biopharma
Robert Ang, M.B.B.S, Chief Executive Officer, received $2.7M in total, which decreased by 40% compared to 2022. 38% of MBBS' compensation, or $1M, was in option awards. MBBS also received $317K in non-equity incentive plan, $606K in salary, $715K in stock awards, as well as $22K in other compensation.
Eyal Attar, Chief Medical Officer, received a compensation package of $1.4M. 34% of the compensation package, or $474K, was in salary.
Tirtha Chakraborty, Chief Scientific Officer, earned $1.3M in 2023, a 31% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 9, 2024.